Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Testosterone injections can cause skin darkening and thickening.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Finasteride improves hair but may reduce sperm quality at higher doses.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.